1. Home
  2. LKQ vs RGEN Comparison

LKQ vs RGEN Comparison

Compare LKQ & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LKQ Corporation

LKQ

LKQ Corporation

HOLD

Current Price

$25.21

Market Cap

6.6B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$169.32

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKQ
RGEN
Founded
1998
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.6B
IPO Year
2003
1995

Fundamental Metrics

Financial Performance
Metric
LKQ
RGEN
Price
$25.21
$169.32
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$42.33
$167.67
AVG Volume (30 Days)
3.1M
967.3K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
3.91%
N/A
EPS Growth
N/A
286.96
EPS
0.84
0.24
Revenue
$13,651,000,000.00
$141,236,000.00
Revenue This Year
$2.18
$14.30
Revenue Next Year
$1.71
$14.52
P/E Ratio
$29.44
$720.58
Revenue Growth
N/A
35.10
52 Week Low
$21.17
$100.99
52 Week High
$37.13
$188.73

Technical Indicators

Market Signals
Indicator
LKQ
RGEN
Relative Strength Index (RSI) 46.14 51.56
Support Level $24.52 $156.65
Resistance Level $26.77 $173.10
Average True Range (ATR) 0.66 7.57
MACD -0.07 -1.89
Stochastic Oscillator 21.86 16.92

Price Performance

Historical Comparison
LKQ
RGEN

About LKQ LKQ Corporation

LKQ Corp is a world-wide distributor of vehicle products, including replacement parts, components and systems used in the repair and maintenance of vehicles, and specialty aftermarket products and accessories to improve the performance, functionality and appearance of vehicles. The company is organized into three operating segments: North America; Europe; and Specialty segment. It derives maximum revenue from Europe Segment. Europe segment is a provider of alternative vehicle replacement and maintenance products in Germany, the United Kingdom, the Benelux region (Belgium, Netherlands, and Luxembourg), Italy, Czech Republic, Austria, Slovakia, France and various other European countries.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: